Medostatin (Lovastatin)

Lovastatin inhibits the enzyme HMG‑CoA reductase, which is essential for cholesterol synthesis in the liver. This inhibition reduces hepatic cholesterol production, leading to increased expression of LDL receptors and enhanced removal of LDL particles from the bloodstream.

The appropriate dose of Medostatin is determined by the prescribing clinician based on the patient’s lipid profile, cardiovascular risk, age, renal and hepatic function, and any concomitant medications. Patients should follow the prescriber’s instructions exactly.

Medostatin is classified as pregnancy category X, meaning it is contraindicated in pregnancy because of potential fetal harm. It is also not recommended while breastfeeding, as lovastatin can pass into breast milk and affect the infant.

To request Medostatin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Medostatin (lovastatin) is a first‑generation statin with a well‑established efficacy profile. Compared with newer agents such as rosuvastatin or atorvastatin, lovastatin may require higher doses to achieve similar LDL reductions and has a higher potential for drug‑drug interactions via CYP3A4.

Medostatin tablets should be stored at room temperature, below 25 °C, in the original blister or bottle. Keep them away from moisture, direct sunlight and excessive heat to maintain product stability.

Medostatin is taken orally, usually once daily in the evening with or without food, as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically advised.

The most serious risks include rhabdomyolysis, a severe muscle breakdown that can lead to kidney failure, and significant liver enzyme elevations indicating hepatic injury. Patients should report unexplained muscle pain, weakness, or dark urine promptly.

Medostatin should not be used by individuals with active liver disease, unexplained persistent elevations of transaminases, known hypersensitivity to lovastatin, or women who are pregnant or may become pregnant. Caution is also advised in severe renal impairment.